McKesson Corporation (NYSE:MCK) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April23, 2019, Jorge Figueredo, Executive Vice President and Chief Human Resources Officer, who is a named executive officer of McKesson Corporation (Company), gave the Company notice of his decision to retire from the Company effective on September30, 2019.
Mr.Figueredo will receive one additional point for purposes of the age plus years of service calculation under certain Company incentive plans, such that certain long-term cash and equity awards granted to him in the last two years will vest in accordance with their original terms, including their original performance conditions. Mr.Figueredo will also receive his fiscal year 2020 annual cash bonus on a prorated basis to reflect the partial year of service prior to his retirement, along with other standard benefits.
Item 5.02 Financial Statements and Exhibits.
(d)Exhibits.
| Press release issued by the Company dated April26, 2019. |
MCKESSON CORP Exhibit
EX-99.1 2 d737061dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Press Release Contact Investors and Financial Media: Holly Weiss | 972-969-9174 | [email protected] General and Business Media: Kristin Chasen | 415-983-8974 | [email protected] McKesson Appoints Tracy Faber to Top HR Role Jorge Figueredo and Kathy McElligott to retire IRVING,…
To view the full exhibit click here
About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
